AVX-012
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AVX-012, covering 2018-10-01 to 2018-10-01. Get the full timeline:
Most recent: Clinical Trial Update: Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome [Phase 1, Phase 2]